Loading clinical trials...
Loading clinical trials...
This is a Phase IV prospective, randomized, open label, comparative, multicenter study in generally healthy postmenopausal women receiving Totelle (17B Estradiol/TMG CC (1mg)) and Livial (Tibolone).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07118891 · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
NCT07335224 · Hot Flashes, Acupuncture Therapy, and more
NCT07238478 · Joint Discomfort, Joint Pain, Stiffness, Function, and more
NCT07022925 · Perimenopause, Perimenopausal Depression, and more
NCT06949553 · Vasomotor Symptoms (VMS) Associated With Menopause
Pfizer Investigational Site
Monterrey, Nuevo León
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions